Department of Biotechnology (DBT) under Ministry of Science and Technology and Department of Atomic Energy (DAE), under Prime Minister of India have signed a memorandum of understanding (MoU) for supporting joint collaborative research programmes in the area of Cancer.
a. Space
b. Defence
c. Cancer
d. Nuclear Energy
About the MoU:
- The MoU for Joint Collaboration on Cancer Research was signed between DBT and DAE.
- The DAE was represented by its Tata Memorial Centre, which also functions as coordinating centre on behalf of The National Cancer Grid of India.
- Their objective is to work towards the common goal of tackling cancer and also to bring a quantum change in the present scenario of Cancer research.
- The Clinicians shall work in coherence with Researchers to identify and develop collaborative research programmes as well as public health initiatives.
- Activities such as intensive workshops on clinical research methodologies, joint clinical fellowships and protocol development shall help towards creating a trained manpower community and will provide a platform to utilize their acquired skills in the best possible manner.
What makes this MoU significant?
- The MoU shall help strengthen various initiatives mandatorily for Cancer by:
- Strategizing and prioritizing cancer research.
- Developing new and affordable technologies.
- Jointly designing and funding clinical trials.
- Coordinating and collaborating for translational research, interventions, training of manpower and infrastructure development.
Question:
Q. Department of Biotechnology (DBT) and Department of Atomic Energy (DAE) have signed a memorandum of understanding (MoU) for supporting joint collaborative research programmes in which area?a. Space
b. Defence
c. Cancer
d. Nuclear Energy
